High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion

Blood. 2016 Feb 4;127(5):637-45. doi: 10.1182/blood-2014-09-599530. Epub 2015 Nov 9.

Abstract

The ability of von Willebrand factor (VWF) to initiate platelet adhesion depends on the number of monomers in individual VWF multimers and on the self-association of individual VWF multimers into larger structures. VWF self-association is accelerated by shear stress. We observed that VWF self-association occurs during adsorption of VWF onto surfaces, assembly of secreted VWF into hyperadhesive VWF strings on the endothelial surface, and incorporation of fluid-phase VWF into VWF fibers. VWF adsorption under static conditions increased with increased VWF purity and was prevented by a component of plasma. We identified that component as high-density lipoprotein (HDL) and its major apolipoprotein ApoA-I. HDL and ApoA-I also prevented VWF on the endothelium from self-associating into longer strands and inhibited the attachment of fluid-phase VWF onto vessel wall strands. Platelet adhesion to VWF fibers was reduced in proportion to the reduction in self-associated VWF. In a mouse model of thrombotic microangiopathy, HDL also largely prevented the thrombocytopenia induced by injection of high doses of human VWF. Finally, a potential role for ApoA-I in microvascular occlusion associated with thrombotic thrombocytopenic purpura and sepsis was revealed by the inverse relationship between the concentration of ApoA-I and that of hyperadhesive VWF. These results suggest that interference with VWF self-association would be a new approach to treating thrombotic disorders.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apolipoprotein A-I / metabolism*
  • Apolipoprotein A-I / therapeutic use
  • Blood Platelets / cytology
  • Blood Platelets / metabolism
  • Humans
  • Lipoproteins, HDL / metabolism*
  • Lipoproteins, HDL / therapeutic use
  • Mice, Inbred C57BL
  • Platelet Adhesiveness*
  • Protein Multimerization
  • Thrombocytopenia / prevention & control
  • Thrombosis / metabolism*
  • von Willebrand Factor / chemistry
  • von Willebrand Factor / metabolism*

Substances

  • Apolipoprotein A-I
  • Lipoproteins, HDL
  • von Willebrand Factor